$SEEL
Seelos Therapeutics Inc

2014 Q3 Form 10-Q Financial Statement

#000101749114000079 Filed on August 11, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q2 2014 Q1
Revenue $1.898M $5.454M $0.00
YoY Change 6678.57% 357.55% -100.0%
Cost Of Revenue $0.00 $75.00K $0.00
YoY Change -100.0% -89.32% -100.0%
Gross Profit $1.413M $5.379M $0.00
YoY Change 10769.23% 997.76% -100.0%
Gross Profit Margin 74.45% 98.62%
Selling, General & Admin $2.720M $2.880M $3.060M
YoY Change -5.23% -23.2% -20.1%
% of Gross Profit 192.5% 53.54%
Research & Development $1.876M $2.103M $1.444M
YoY Change 104.13% 37.0% 2.19%
% of Gross Profit 132.77% 39.1%
Depreciation & Amortization $60.00K $20.00K $20.00K
YoY Change 200.0% 0.0% -4.76%
% of Gross Profit 4.25% 0.37%
Operating Expenses $4.595M $4.134M $3.543M
YoY Change 44.68% -9.0% -32.37%
Operating Profit -$3.182M $1.245M -$3.543M
YoY Change 0.6% -130.72% -42.49%
Interest Expense -$44.00K -$69.00K -$107.0K
YoY Change -74.71% -67.61% -53.68%
% of Operating Profit -5.54%
Other Income/Expense, Net $50.00K -$40.00K $281.0K
YoY Change -238.89% 21.21% -135.61%
Pretax Income -$3.130M $1.210M -$3.260M
YoY Change -2.19% -129.58% -53.09%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$3.113M $1.877M -$3.262M
YoY Change 4.29% -147.7% -62.39%
Net Earnings / Revenue -164.01% 34.42%
Basic Earnings Per Share -$0.08 $0.05 -$0.09
Diluted Earnings Per Share -$0.08 $0.05 -$0.09
COMMON SHARES
Basic Shares Outstanding 38.10M shares 37.90M shares 37.90M shares
Diluted Shares Outstanding 37.91M shares

Balance Sheet

Concept 2014 Q3 2014 Q2 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.11M $17.42M $22.49M
YoY Change -21.87% -29.64% 59.5%
Cash & Equivalents $16.11M $17.42M $22.49M
Short-Term Investments
Other Short-Term Assets $1.110M $990.0K $620.0K
YoY Change 65.67% 65.0% -36.73%
Inventory $321.0K $377.0K $364.0K
Prepaid Expenses
Receivables $829.0K $49.00K $69.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $18.37M $18.83M $23.54M
YoY Change -15.19% -28.44% 51.07%
LONG-TERM ASSETS
Property, Plant & Equipment $1.319M $1.347M $1.360M
YoY Change 140.26% 137.99% 121.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $106.0K $105.0K $93.00K
YoY Change 17.78% 176.32% -5.1%
Total Long-Term Assets $1.425M $1.452M $1.453M
YoY Change 123.0% 140.4% 39.04%
TOTAL ASSETS
Total Short-Term Assets $18.37M $18.83M $23.54M
Total Long-Term Assets $1.425M $1.452M $1.453M
Total Assets $19.80M $20.29M $24.99M
YoY Change -11.23% -24.65% 50.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.220M $1.130M $990.0K
YoY Change 96.77% -22.6% -46.49%
Accrued Expenses $1.825M $1.807M $1.979M
YoY Change -16.28% -33.0% -47.0%
Deferred Revenue
YoY Change
Short-Term Debt $1.200M $1.180M $2.660M
YoY Change -16.67% -54.09% 88.65%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.386M $6.969M $14.58M
YoY Change -23.98% -36.66% 43.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $58.00K $69.00K $80.00K
YoY Change -54.33% -48.89% -63.3%
Total Long-Term Liabilities $58.00K $69.00K $80.00K
YoY Change -54.33% -48.89% -63.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.386M $6.969M $14.58M
Total Long-Term Liabilities $58.00K $69.00K $80.00K
Total Liabilities $7.800M $7.038M $14.66M
YoY Change -24.67% -47.98% -14.95%
SHAREHOLDERS EQUITY
Retained Earnings -$272.6M -$269.5M -$271.3M
YoY Change 2.19% 2.17% 4.44%
Common Stock $284.6M $281.3M $280.2M
YoY Change 2.11% 1.5% 8.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.00M $11.85M $8.890M
YoY Change
Total Liabilities & Shareholders Equity $19.80M $20.29M $24.99M
YoY Change -11.23% -24.65% 50.31%

Cashflow Statement

Concept 2014 Q3 2014 Q2 2014 Q1
OPERATING ACTIVITIES
Net Income -$3.113M $1.877M -$3.262M
YoY Change 4.29% -147.7% -62.39%
Depreciation, Depletion And Amortization $60.00K $20.00K $20.00K
YoY Change 200.0% 0.0% -4.76%
Cash From Operating Activities -$4.080M -$4.630M -$192.0K
YoY Change -5.77% -9.22% -97.16%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K -$70.00K $355.0K
YoY Change -12.5% 859.46%
Acquisitions
YoY Change
Other Investing Activities $0.00 $680.0K $50.00K
YoY Change -100.0% 518.18% -98.97%
Cash From Investing Activities -$60.00K $600.0K -$305.0K
YoY Change -137.5% 1400.0% -106.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.641M
YoY Change 107.46%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.840M -1.040M $1.583M
YoY Change 9366.67% -106.57% 100.38%
NET CHANGE
Cash From Operating Activities -4.080M -4.630M -$192.0K
Cash From Investing Activities -60.00K 600.0K -$305.0K
Cash From Financing Activities 2.840M -1.040M $1.583M
Net Change In Cash -1.300M -5.070M $1.086M
YoY Change -68.6% -147.03% -194.43%
FREE CASH FLOW
Cash From Operating Activities -$4.080M -$4.630M -$192.0K
Capital Expenditures -$70.00K -$70.00K $355.0K
Free Cash Flow -$4.010M -$4.560M -$547.0K
YoY Change -7.39% -9.16% -91.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1737000 USD
CY2013Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
926000 USD
CY2014Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1128000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59000 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49000 USD
us-gaap Accretion Expense
AccretionExpense
174000 USD
us-gaap Accretion Expense
AccretionExpense
0 USD
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
148000 USD
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
106000 USD
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
952000 USD
CY2014Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
758000 USD
CY2013Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
168000 USD
CY2014Q2 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
146000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2119000 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1807000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
997000 USD
CY2014Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
692000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
279000000 USD
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
281260000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
700000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1036000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
200000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
100000 USD
CY2013Q4 us-gaap Assets
Assets
23310000 USD
CY2014Q2 us-gaap Assets
Assets
20285000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
22264000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
18833000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21405000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17420000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24764000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15130000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3985000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9634000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
1500000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
675000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-3000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-359000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37541404 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38102451 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38102451 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37541404 shares
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
38000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
38000 USD
CY2014Q2 us-gaap Contracts Revenue
ContractsRevenue
0 USD
CY2013Q2 us-gaap Contracts Revenue
ContractsRevenue
555000 USD
us-gaap Contracts Revenue
ContractsRevenue
1452000 USD
us-gaap Contracts Revenue
ContractsRevenue
0 USD
CY2014Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1181000 USD
CY2013Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2600000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2553000 USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
75000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
702000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
75000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
672000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
42000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41000 USD
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
517000 USD
CY2014Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
95000 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.02
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.05
CY2013 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1250000 USD
CY2014Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1225000 USD
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2750000 USD
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
150000 USD
CY2014Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
44000 USD
CY2013 us-gaap Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts
DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts
200000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
641000 USD
CY2013Q2 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
641000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
846000 USD
CY2014Q2 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
846000 USD
CY2013Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
487000 USD
CY2014Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
400000 USD
CY2013Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
184000 USD
CY2014Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
175000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1800000 USD
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2000000 USD
CY2014Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1000000 USD
CY2013Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.00
CY2014Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.02
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.02
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.05
CY2014Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.02
CY2013Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.00
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
432000 USD
CY2014Q2 us-gaap Escrow Deposit
EscrowDeposit
300000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-422000 USD
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
517000 USD
CY2014Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
95000 USD
CY2013Q2 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2014Q2 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
910000 USD
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
50000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6969000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11760000 USD
us-gaap Licenses Revenue
LicensesRevenue
669000 USD
us-gaap Licenses Revenue
LicensesRevenue
5454000 USD
CY2013Q2 us-gaap Licenses Revenue
LicensesRevenue
637000 USD
CY2014Q2 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
0 USD
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
105000 USD
CY2013Q2 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
105000 USD
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
50000 USD
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
105000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7580000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2877000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3754000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5936000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
490000 USD
us-gaap Gross Profit
GrossProfit
5379000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
5379000 USD
us-gaap Gross Profit
GrossProfit
-432000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11036000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1205000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2057000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4086000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.06
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.12
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.03
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.35
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.12
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-176000 USD
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.35
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.03
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.06
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
151000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1572000 USD
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
672000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-386000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
202000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
370000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-298000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
516000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-647000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-194000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-87000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-100000 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-422000 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
375000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
249000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
41000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
14000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-19000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
158000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
473000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-13000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
280000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-444000 USD
CY2013Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-213000 USD
CY2014Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-69000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0 USD
CY2014Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
101000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
336000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
377000 USD
CY2014Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
160000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
209000 USD
CY2014Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
116000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
127000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20285000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23310000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-80000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
417000 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-378000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
180000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2014Q2 us-gaap Licenses Revenue
LicensesRevenue
5454000 USD
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
1141000 USD
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
672000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
16633000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
542000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-382000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
3366000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4817000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-11506000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12608000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1385000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-3935000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
1877000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-822000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
241000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-40000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-33000 USD
CY2014Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
4543000 USD
us-gaap Operating Expenses
OperatingExpenses
7677000 USD
us-gaap Operating Expenses
OperatingExpenses
9782000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
4134000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4053000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1245000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10214000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2298000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
472000 USD
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
320000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
105000 USD
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
69000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
91000 USD
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
17000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
25000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1535000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2948000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3547000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2103000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
116000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
605000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
132000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16612000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2176000 USD
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
0 USD
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
-50000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-1525000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
CY2014Q2 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-1525000 USD
CY2013 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3657000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
105000 USD
us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
50000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
46000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
955000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1347000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
332000 USD
CY2014Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
382000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-269451000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-268066000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1192000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
5454000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2121000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
5454000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2176000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1238000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1036000 USD
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
486923 shares
CY2013 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
486923 shares
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
11847000 USD
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
42000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
10972000 USD
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37907000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37886000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32825000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31509000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37901000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37886000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31509000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32825000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32825000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37901000 shares
CY2014Q2 apri Deliverables In Arrangement
DeliverablesInArrangement
2 deliverable
apri Increase Decrease In Deferred Revenue Long Term
IncreaseDecreaseInDeferredRevenueLongTerm
0 USD
apri Increase Decrease In Deferred Revenue Long Term
IncreaseDecreaseInDeferredRevenueLongTerm
1000000 USD
apri Increase Decrease In Short Term Liability Arising From Deconsolidation Of Subsidiaries
IncreaseDecreaseInShortTermLiabilityArisingFromDeconsolidationOfSubsidiaries
0 USD
apri Increase Decrease In Short Term Liability Arising From Deconsolidation Of Subsidiaries
IncreaseDecreaseInShortTermLiabilityArisingFromDeconsolidationOfSubsidiaries
-2000000 USD
apri Increase Decreasein Deferred Revenue Short Term
IncreaseDecreaseinDeferredRevenueShortTerm
-715000 USD
apri Increase Decreasein Deferred Revenue Short Term
IncreaseDecreaseinDeferredRevenueShortTerm
200000 USD
CY2012 apri Other Noncash Investingand Financing Items Releaseof Obligations Relatedto Short Term Loans
OtherNoncashInvestingandFinancingItemsReleaseofObligationsRelatedtoShortTermLoans
270000 USD
apri Other Noncash Investingand Financing Items Releaseof Obligations Relatedto Short Term Loans
OtherNoncashInvestingandFinancingItemsReleaseofObligationsRelatedtoShortTermLoans
0 USD
CY2013Q4 apri Research And Development Accrued Expense
ResearchAndDevelopmentAccruedExpense
298000 USD
CY2014Q2 apri Research And Development Accrued Expense
ResearchAndDevelopmentAccruedExpense
474000 USD
CY2013Q4 apri Short Term Liability Arising From Deconsolidation Of French Subsidiaries
ShortTermLiabilityArisingFromDeconsolidationOfFrenchSubsidiaries
2846000 USD
CY2014Q2 apri Short Term Liability Arising From Deconsolidation Of French Subsidiaries
ShortTermLiabilityArisingFromDeconsolidationOfFrenchSubsidiaries
0 USD
apri Stock Returned From Contract Settlement Value
StockReturnedFromContractSettlementValue
910000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001017491
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38102451 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
APRICUS BIOSCIENCES, INC.
dei Trading Symbol
TradingSymbol
APRI

Files In Submission

Name View Source Status
0001017491-14-000079-index-headers.html Edgar Link pending
0001017491-14-000079-index.html Edgar Link pending
0001017491-14-000079.txt Edgar Link pending
0001017491-14-000079-xbrl.zip Edgar Link pending
apri-20140630.xml Edgar Link completed
apri-20140630.xsd Edgar Link pending
apri-20140630_cal.xml Edgar Link unprocessable
apri-20140630_def.xml Edgar Link unprocessable
apri-20140630_lab.xml Edgar Link unprocessable
apri-20140630_pre.xml Edgar Link unprocessable
apri-201463010xq.htm Edgar Link pending
apri-2014630xex101.htm Edgar Link pending
apri-2014630xex102.htm Edgar Link pending
apri-2014630xex21.htm Edgar Link pending
apri-2014630xex311.htm Edgar Link pending
apri-2014630xex312.htm Edgar Link pending
apri-2014630xex321.htm Edgar Link pending
apri-2014630xex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending